Novavax Covid vaccine approved for use in over-18s in UK
by Hannah Devlin Science correspondent from World news | The Guardian on (#5VR21)
Nuvaxovid is similar to flu jab and may have reduced side-effects, which could persuade vaccine holdouts
The Covid-19 vaccine developed by Novavax has been approved by the UK regulator for use in people over the age of 18.
The vaccine will not be immediately widely available as its use as part of the UK's vaccination programme will be considered by the independent Joint Committee on Vaccination and Immunisation.
Continue reading...